Presentation Information

[3P-0461]Dual inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic ductal adenocarcinoma

○Takako Ooshio1,2, Yusuke Satoh2, Hui Jian2, Tongwei Liu2, Takuya Otsuka2, Kiyonaga Fujii3, Takamasa Ishikawa4, Kaori Igarashi4, Kaori Saitoh4, Keiko Kato4, Tomoyoshi Soga4, Koji Tsuta1, Masahiro Sonoshita2 (1.Kansai Medical University, 2.Hokkaido University, 3.Yokohama University of Pharmacy, 4.Keio University)

Password required to view

Password required to view or download.
Check your name badge for the password.

Comment

To browse or post comments, you must log in.Log in